Dr. Gaston speaking to a group

2014 Scholar-Innovators

Jayakrishna Ambati, MD

Jayakrishna Ambati, MD

University of Kentucky

Development of novel therapeutics to treat Age-related Macular Degeneration

Darren R. Carpizo, MD, PhD

Darren R. Carpizo, MD, PhD

Rutgers Cancer Institute of New Jersey

Development of a first-in-kind anticancer drug that restores the function of a commonly mutated gene found in cancer

Garret A. FitzGerald, MD

Garret A. FitzGerald, MD

University of Pennsylvania

Development of a novel therapeutic for the treatment of hypertension and atherosclerotic disease

Mark S. Humayun, MD, PhD

Mark S. Humayun, MD, PhD

University of Southern California

Development of an innovative oxygen delivery device to treat ischemic retinal disease, a leading cause of blindness worldwide

John N. Kheir, MD

John N. Kheir, MD

Boston Children’s Hospital

Development of an injectable form of oxygen to prevent life-threatening hypoxemia in medical emergencies such as cardiac arrest

Rahul M. Kohli, MD, PhD

Rahul M. Kohli, MD, PhD

University of Pennsylvania

Development of a novel approach to circumvent bacterial antibiotic resistance in diseases such as cystic fibrosis, tuberculosis and hospital-acquired infections

Gavril W. Pasternak, MD, PhD

Gavril W. Pasternak, MD, PhD

Memorial Sloan-Kettering Cancer Center

Development of a novel class of analgesics more potent than morphine, but lacking the negative side effects and abuse potential

Irina Petrache, MD

Irina Petrache, MD

Indiana University

Development of a first-to-market disease-modifying therapy for patients with COPD, the third leading cause of death in the U.S.

David H. Rowitch, MD, PhD

David H. Rowitch, MD, PhD

University of California, San Francisco

Development of a novel therapeutic approach to treat neonatal brain injury, Down syndrome, and stroke

Jean Y. Tang, MD, PhD

Jean Y. Tang, MD, PhD

Stanford University

Development of a novel topical drug for the treatment and prevention of BCC, a common form of skin cancer that affects millions worldwide

Watch Video

David Wald, MD, PhD

David Wald, MD, PhD

Case Western Reserve University

Development of a novel therapeutic to treat AML, the most common form of leukemia in adults

The Harrington Project for Discovery & Development

Discover
Advance
Commercialize
Breakthrough Medicine